| (USD) | Dec 2007 | Y/Y change |
|---|---|---|
| Revenue | 176.00K | — |
| Operating expense | — | — |
| Net income | 0.00 | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, ELTP returned -47.5% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -41.1% |
| 1 year | -47.5% |
| 5 years | +477.0% |
| 10 years | +31.1% |
| All-time high | $14.25 (Feb 2000) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in ELTP would be worth today ›No. Elite Pharmaceuticals, Inc. has not paid a dividend in the past 12 months.
Elite Pharmaceuticals, Inc. is part of the Healthcare sector.
Elite Pharmaceuticals, Inc. has a market cap of 310.75M USD, based on the latest quote.
Elite Pharmaceuticals, Inc. is expected to report earnings around Nov 12, 2026. That date is an estimate and has not been confirmed by the company.
